NeuroDerm's Grant - II Round

NeuroDerm raised a round of funding on June 03, 2013. Investors include The Michael J. Fox Foundation.

NeuroDerm is a clinical-stage pharmaceutical company developing central nervous system (CNS) product candidates that are designed to overcome major deficiencies of current treatments and achieve enhan…

Articles about NeuroDerm's Grant - II Round: